Release Date: 11/05/11 11:18 Summary: Roodekop Resource Upgrade / 50% interest achieved Price Sensitive: Yes Download Document 792.46KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%